Hyperfine (NASDAQ:HYPR – Get Free Report) and Nexalin Technology (NASDAQ:NXL – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, institutional ownership, risk, earnings, profitability, analyst recommendations and valuation. Analyst Recommendations This is a breakdown of recent […]